Tag: COVID-19 single-dose vaccine
Johnson & Johnson COVID-19 vaccine is 66% effective in global trial,...
FRI 29 JAN, 2021-theGBJournal- Johnson & Johnson announced today that its COVID-19 single-dose vaccine candidate was 66% effective overall in preventing moderate to severe...
